Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Top 50 Companies 2017: Notes & Methodology

For this annual special report, which is in its 31st year of publication, Med Ad News editors rank and profile the world’s top 50 companies that generate revenue from healthcare products.

Read More »

2017 Annual Report: Top 50 Companies – The Corner Turned

For the pharmaceutical industry, 2016 brought new blockbusters onto the market to ease the pain of patent expirations.

Read More »

AbbVie 2017: Humira, And What’s Next

While the world’s leading prescription drug Humira still accounts for the majority of AbbVie’s revenue, plenty else is bubbling up at the almost-five-year-old company.

Read More »

Amgen 2017: New Business Cycle

Amgen is featuring an unprecedented collection of new product offerings, including the first-ever biosimilar cancer treatment to receive U.S. marketing clearance.

Read More »

AstraZeneca 2017: Eyes To The Future

Although patent expirations continue to depress revenue, AstraZeneca executives believe in the pipeline.

Read More »

Bayer 2017: Monsanto & Oncology

For Bayer, the acquisition of Monsanto is intended to build its Crop Science division; meanwhile two significant approvals and two new hires enhance progress in oncology.

Read More »

Bristol-Myers Squibb 2017: Opdivo Steps Up

After years of hope and hype, Bristol-Myers Squibb’s centerpiece immuno-oncologic Opdivo is delivering the dollars.

Read More »

Gilead 2017: We Got Next

With sales of Harvoni and Sovaldi falling off, Gilead welcomed two new blockbusters to the company’s portfolio in 2016.

Read More »

GlaxoSmithKline 2017: New Business Priorities

Management set out a series of new priorities to 2020 to improve innovation, performance and trust in GlaxoSmithKline.

Read More »

Johnson & Johnson 2017: Transformational Innovation And Growth

With proven worldwide commercial capabilities and a robust product pipeline, Johnson & Johnson is firmly positioned to continue generating strong, long-term, sustainable growth.

Read More »

Lilly 2017: A New Administration

New CEO David Ricks took over Lilly as the company continues to climb out of its post-Cymbalta/Zyprexa rut.

Read More »

Merck 2017: Key(truda) To The Kingdom

Easily the fastest grower in Merck’s portfolio, the oncology drug Keytruda is piling up dollars and indications at an impressive rate.

Read More »

Novartis 2017: Back To The Future

2017 is serving as another challenging year for Novartis as the company continues to work through the Gleevec/Glivec patent expirations that began in 2016, but management is confident that a new phase of growth will start in 2018.

Read More »

Novo Nordisk 2017: Pushing Ahead

Novo Nordisk executives believe that the company is on a path that will create growth in 2017 and beyond.

Read More »

Pfizer 2017: Beyond The Blockbusters

Pfizer is overcoming patent expirations by developing a steady new stream of products.

Read More »

Company Of The Year 2017 – Roche: Surging Ahead Via Innovation

Roche’s Pharmaceuticals and Diagnostics Divisions continue to generate strong performances significantly driven by new product launches, including four new oncology treatments and the company’s first cancer immunotherapy medicine.

Read More »

Sanofi 2017: Weathering Patent Erosion

Sanofi executives continue to have faith in strategic plans to get the company to new heights despite continued impact from patent expirations.

Read More »

Teva: Too Many Cooks?

Now on its seventh CEO in the last 10 years and in danger of losing its most valuable branded product, Teva is searching for answers.

Read More »

2017 HBA Annual Conference

HBA’s 2017 Annual Conference will be held in Philadelphia on Nov. 6-8, 2017.

Read More »

Top 50 Companies: Healthcare Revenue

A listing of the top 50 companies ranked by healthcare revenue.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2018 Focus: Top 50 Pharma, Company of the Year and more!


Ad Right Bottom